{"id":77670,"date":"2021-11-11T16:09:00","date_gmt":"2021-11-11T15:09:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=77670"},"modified":"2021-11-11T10:12:40","modified_gmt":"2021-11-11T09:12:40","slug":"eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/77670\/eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government\/","title":{"rendered":"Eisbach Bio receives 6.7 million euros from the Bavarian State Government"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Already in July 2021, Eisbach Bio received a <a href=\"\/en\/74446\/eisbach-bio-receives-8-million-euros-in-state-funding\/\">Funding of over 8 million euros<\/a> from the Federal Ministry of Education and Research. Now, the Bavarian State Ministry for Economic Affairs, Regional Development and Energy is also supporting the preclinical and clinical development of an active ingredient against the coronavirus SARS-CoV-2. The funding is intended to maintain the competitiveness of the biotech scene in Bavaria. Eisbach Bio is located in the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried near Munich. The Eisbach CEO <strong>Adrian Schomburg <\/strong>says: <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;Our team is grateful for the government support in developing our drug candidates. The biotech scene in Bavaria and beyond will benefit from this project. Our research progress demonstrates how Bavarian companies are committed to the fight against COVID-19 and are playing a leading role in developing innovations and therapeutic solutions.&quot;<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Eisbach Bio: \u201cUrgently needed new antiviral drug for the global community\u201d<\/h2>\n\n\n\n<p><strong>Andreas Ladurner<\/strong>, CSO at Eisbach Bio, adds: <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are committed to developing a sustainable drug with a good safety profile. The funded BayTherapy2020 program will allow us to allocate more resources to the research and development of EIS4363, significantly increasing our chances of developing a much-needed new antiviral drug for the global community.&quot;<\/p><\/blockquote>\n\n\n\n<p>Eisbach&#039;s goal is to bring a safe, sustainable, and targeted antiviral drug with specific activity against the SARS-CoV-2 virus into the clinic. This will slow the progression of the disease and end the pandemic worldwide. The company plans to begin Phase I clinical trials for its drug in the second quarter of 2022. <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are very proud that a startup from the IZB is making a significant contribution to the global fight against the coronavirus pandemic. We wish the Eisbach Bio team every success in implementing their innovative technology,&quot; <\/p><\/blockquote>\n\n\n\n<p>says <strong>Peter Hanns Zobel<\/strong>, Managing Director of the IZB.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based biotech company Eisbach Bio has received \u20ac6.7 million in funding for the development of antiviral agents against SARS-CoV-2. With the funding, clinical trials are expected to begin next year.<\/p>","protected":false},"author":26,"featured_media":77671,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[371,3882,4344,52],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung<\/title>\n<meta name=\"description\" content=\"Eisbach Bio bekommt eine F\u00f6rderung in H\u00f6he von 6,7 Millionen Euro f\u00fcr die Entwicklung antiviraler Wirkstoffe gegen SARS-CoV-2.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/77670\/eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung\" \/>\n<meta property=\"og:description\" content=\"Eisbach Bio bekommt eine F\u00f6rderung in H\u00f6he von 6,7 Millionen Euro f\u00fcr die Entwicklung antiviraler Wirkstoffe gegen SARS-CoV-2.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/77670\/eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-11T15:09:00+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/\",\"url\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/\",\"name\":\"Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg\",\"datePublished\":\"2021-11-11T15:09:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Eisbach Bio bekommt eine F\u00f6rderung in H\u00f6he von 6,7 Millionen Euro f\u00fcr die Entwicklung antiviraler Wirkstoffe gegen SARS-CoV-2.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg\",\"width\":2400,\"height\":1597,\"caption\":\"Adrian Schomburg, CEO bei Eisbach Bio\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1597\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eisbach Bio receives 6.7 million euros from the Bavarian State Government","description":"Eisbach Bio receives funding of 6.7 million euros for the development of antiviral agents against SARS-CoV-2.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/77670\/eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government\/","og_locale":"en_US","og_type":"article","og_title":"Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung","og_description":"Eisbach Bio bekommt eine F\u00f6rderung in H\u00f6he von 6,7 Millionen Euro f\u00fcr die Entwicklung antiviraler Wirkstoffe gegen SARS-CoV-2.","og_url":"https:\/\/cms.munich-startup.net\/en\/77670\/eisbach-bio-receives-67-million-euros-from-the-bavarian-state-government\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2021-11-11T15:09:00+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/","url":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/","name":"Eisbach Bio receives 6.7 million euros from the Bavarian State Government","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg","datePublished":"2021-11-11T15:09:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"Eisbach Bio receives funding of 6.7 million euros for the development of antiviral agents against SARS-CoV-2.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg","width":2400,"height":1597,"caption":"Adrian Schomburg, CEO bei Eisbach Bio"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/77670\/eisbach-bio-erhaelt-67-millionen-euro-von-der-bayerischen-staatsregierung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Eisbach Bio erh\u00e4lt 6,7 Millionen Euro von der Bayerischen Staatsregierung"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":2400,"height":1597,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/11\/DZ6_6744.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1636623841:24","_edit_last":"26","_yoast_wpseo_focuskw":"Eisbach","_yoast_wpseo_metadesc":"Eisbach Bio bekommt eine F\u00f6rderung in H\u00f6he von 6,7 Millionen Euro f\u00fcr die Entwicklung antiviraler Wirkstoffe gegen SARS-CoV-2.","_yoast_wpseo_linkdex":"75","_thumbnail_id":"77671","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"%%title%% %%page%%","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/77670"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=77670"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/77670\/revisions"}],"predecessor-version":[{"id":77673,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/77670\/revisions\/77673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/77671"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=77670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=77670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=77670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}